Maraviroc: a new CCR5 antagonist
S Sayana, H Khanlou - Expert review of anti-infective therapy, 2009 - Taylor & Francis
Maraviroc is a small molecule and a member of a new class of antiretroviral compounds
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
Maraviroc: a new CCR5 antagonist
S Sayana, H Khanlou - Expert review of anti-infective …, 2009 - pubmed.ncbi.nlm.nih.gov
Maraviroc is a small molecule and a member of a new class of antiretroviral compounds
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
Maraviroc: a new CCR5 antagonist
S Sayana, H Khanlou - Expert Review of Anti-infective Therapy, 2009 - go.gale.com
At present, the only means to hamper HIV disease progression is the use of highly active
antiretroviral therapy (HAART). After initial HAART regimens are exhausted, subsequent …
antiretroviral therapy (HAART). After initial HAART regimens are exhausted, subsequent …
Maraviroc: a new CCR5 antagonist.
S Sayana, H Khanlou - Expert Review of Anti-infective Therapy, 2009 - europepmc.org
Maraviroc is a small molecule and a member of a new class of antiretroviral compounds
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
Maraviroc: a new CCR5 antagonist.
S Sayana, H Khanlou - 2009 - cabidigitallibrary.org
Maraviroc is a small molecule and a member of a new class of antiretroviral compounds
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
Maraviroc: a new CCR5 antagonist
S Sayana, H Khanlou - Expert Review of Anti-Infective …, 2009 - search.proquest.com
Maraviroc is a small molecule and a member of a new class of antiretroviral compounds
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …
known as CCR5 antagonists, which block R5-tropic HIV entry into CD4 cells. HIV entry into …